Works matching DE "RENAL cell carcinoma"
Results: 5000
Papillary renal cell carcinoma revisited: impact of the World Health Organization 2022 classification on prognostication.
- Published in:
- BJU International, 2025, v. 135, n. 3, p. 510, doi. 10.1111/bju.16590
- By:
- Publication type:
- Article
Adjuvant immunotherapy for high‐risk renal cell carcinoma—now or never?
- Published in:
- BJU International, 2025, v. 135, n. 2, p. 235, doi. 10.1111/bju.16584
- By:
- Publication type:
- Article
Differences in mutations across tumour sizes in clear‐cell renal cell carcinoma.
- Published in:
- BJU International, 2025, v. 135, n. 2, p. 269, doi. 10.1111/bju.16527
- By:
- Publication type:
- Article
Exploiting NRF2‐ARE pathway activation in papillary renal cell carcinoma.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 7, p. 1457, doi. 10.1002/ijc.35311
- By:
- Publication type:
- Article
Clinical outcomes by baseline metastases in patients with renal cell carcinoma treated with lenvatinib plus pembrolizumab versus sunitinib: Post hoc analysis of the CLEAR trial.
- Published in:
- International Journal of Cancer, 2025, v. 156, n. 7, p. 1326, doi. 10.1002/ijc.35288
- By:
- Publication type:
- Article
Editorial Comment from Dr. Nohara on "Intraoperative tumor capsule injury in patients with renal cell carcinoma receiving partial nephrectomy".
- Published in:
- International Journal of Urology, 2025, v. 32, n. 2, p. 181, doi. 10.1111/iju.15636
- By:
- Publication type:
- Article
Intraoperative tumor capsule injury in patients with renal cell carcinoma receiving partial nephrectomy.
- Published in:
- International Journal of Urology, 2025, v. 32, n. 2, p. 173, doi. 10.1111/iju.15617
- By:
- Publication type:
- Article
Survival improvement over time in renal cell carcinoma treated with nephrectomy: A longitudinal propensity score‐matched study.
- Published in:
- International Journal of Urology, 2025, v. 32, n. 2, p. 145, doi. 10.1111/iju.15610
- By:
- Publication type:
- Article
This issue of the International Journal of Urology contains many articles: Two review articles, 11 original articles, four urological notes, and 10 editorial comments.
- Published in:
- International Journal of Urology, 2025, v. 32, n. 1, p. 6, doi. 10.1111/iju.15645
- By:
- Publication type:
- Article
Editorial comment on the Role of cytoreductive nephrectomy in the era of immune checkpoint inhibitors: A review of current evidence and ongoing trials.
- Published in:
- International Journal of Urology, 2025, v. 32, n. 1, p. 14, doi. 10.1111/iju.15618
- By:
- Publication type:
- Article
The role of cytoreductive nephrectomy in the era of immune checkpoint inhibitors: A review of current evidence and ongoing trials.
- Published in:
- International Journal of Urology, 2025, v. 32, n. 1, p. 7, doi. 10.1111/iju.15594
- By:
- Publication type:
- Article
Choosing the optimal therapy for metastatic renal cell carcinoma: Insights from a real‐world comparative study.
- Published in:
- International Journal of Urology, 2025, v. 32, n. 1, p. 29, doi. 10.1111/iju.15590
- By:
- Publication type:
- Article
Investigating the Effects of Reconstruction Conditions on Image Quality and Radiomic Analysis in Photon-counting Computed Tomography.
- Published in:
- Journal of Medical Physics, 2025, v. 50, n. 1, p. 100, doi. 10.4103/jmp.jmp_114_24
- By:
- Publication type:
- Article
Targeting HIF-2α: the role of belzutifan in clear cell renal carcinoma management.
- Published in:
- Expert Review of Clinical Pharmacology, 2025, v. 18, n. 1/2, p. 17, doi. 10.1080/17512433.2024.2436433
- By:
- Publication type:
- Article
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma – Today's impact, tomorrow's potential.
- Published in:
- Expert Review of Medical Devices, 2024, v. 21, n. 1/2, p. 55, doi. 10.1080/17434440.2023.2293919
- By:
- Publication type:
- Article
Management of oligometastatic and oligoprogressive renal cell carcinoma: an updated review.
- Published in:
- Expert Review of Anticancer Therapy, 2025, v. 25, n. 3, p. 201, doi. 10.1080/14737140.2025.2464929
- By:
- Publication type:
- Article
Persisting challenges in the development of predictive biomarkers for immuno-oncology therapies for renal cell carcinoma.
- Published in:
- Expert Review of Anticancer Therapy, 2025, v. 25, n. 2, p. 97, doi. 10.1080/14737140.2025.2457373
- By:
- Publication type:
- Article
Girentuximab imaging in renal cancer: diamond in the rough or just ZIRCON?
- Published in:
- Expert Review of Anticancer Therapy, 2025, v. 25, n. 2, p. 91, doi. 10.1080/14737140.2025.2454483
- By:
- Publication type:
- Article
2024 ASCO genitourinary cancers symposium: a focus on renal cell carcinoma.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 8, p. 657, doi. 10.1080/14737140.2024.2370382
- By:
- Publication type:
- Article
Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 8, p. 693, doi. 10.1080/14737140.2024.2362192
- By:
- Publication type:
- Article
Neopterin as a potential prognostic and predictive biomarker in metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 6, p. 339, doi. 10.1080/14737140.2024.2341734
- By:
- Publication type:
- Article
Post‐marketing surveillance data for avelumab + axitinib treatment in patients with advanced renal cell carcinoma in Japan: Subgroup analyses by pathological classification.
- Published in:
- International Journal of Urology, 2025, v. 32, n. 3, p. 293, doi. 10.1111/iju.15646
- By:
- Publication type:
- Article
PRSS53 is a potential novel biomarker related to prognosis and immunity in clear cell renal cell carcinoma.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02114-0
- By:
- Publication type:
- Article
Robotic multiquadrant surgery for synchronous neoplasms: The value of a multidisciplinary approach—A video vignette.
- Published in:
- Colorectal Disease, 2025, v. 27, n. 2, p. 1, doi. 10.1111/codi.17291
- By:
- Publication type:
- Article
Epigenetic Alterations in Renal Clear Cell Carcinoma: A Comprehensive Expression and Clinical Outcome Analysis.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2025, v. 2025, p. 1, doi. 10.1155/jcpt/5520198
- By:
- Publication type:
- Article
Influence of the type of anaesthesia on acute kidney injury after nephrectomy: a randomised controlled trial.
- Published in:
- Anaesthesia, 2025, v. 80, n. 3, p. 278, doi. 10.1111/anae.16490
- By:
- Publication type:
- Article
Real-world comparison of the efficacy of first-line therapies and the influence of risk factors in advanced renal cell carcinoma.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02131-z
- By:
- Publication type:
- Article
Pan-cancer analysis of the prognosis and immune infiltration of NSUN7 and its potential function in renal clear cell carcinoma.
- Published in:
- Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-025-02061-w
- By:
- Publication type:
- Article
Genotype Phenotype Correlation of Renal Tumors in the Cancer Genome Atlas Database.
- Published in:
- International Journal of Surgical Pathology, 2025, v. 33, n. 2, p. 289, doi. 10.1177/10668969241260236
- By:
- Publication type:
- Article
Clear Cell Renal Cell Carcinoma: A Comprehensive Review of its Histopathology, Genetics, and Differential Diagnosis.
- Published in:
- International Journal of Surgical Pathology, 2025, v. 33, n. 2, p. 265, doi. 10.1177/10668969241256111
- By:
- Publication type:
- Article
Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae369
- By:
- Publication type:
- Article
Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach.
- Published in:
- Oncologist, 2025, v. 30, n. 2, p. 1, doi. 10.1093/oncolo/oyae337
- By:
- Publication type:
- Article
Hereditary cutaneous leiomyomatosis and low‐grade glioma due to a fumarate hydratase mutation.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 2, p. e122, doi. 10.1111/jdv.20139
- By:
- Publication type:
- Article
A Case Series of Six Patients With Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus Who Underwent Robotic‐Assisted Radical Nephrectomy.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Concomitant Robot‐Assisted Partial Nephrectomy and Pyelolithotomy for Small Renal Cell Carcinoma and Partial Staghorn Calculus in the Same Kidney: A Case Report and Literature Review.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
A Report of a Rare Case of Hurthle Cell Carcinoma of Thyroid with Metachronous Renal Metastasis.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Caki-1 Spheroids as a Renal Model for Studying Free Fatty Acid-Induced Lipotoxicity.
- Published in:
- Cells (2073-4409), 2025, v. 14, n. 5, p. 349, doi. 10.3390/cells14050349
- By:
- Publication type:
- Article
A combinatorial screening protocol for identifying novel and highly potent dual-target inhibitor of BRD4 and STAT3 for kidney cancer therapy.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1560559
- By:
- Publication type:
- Article
The feedback loop between miR-222-3p and ZEB1 harnesses metastasis in renal cell carcinoma.
- Published in:
- Cell Death Discovery, 2025, v. 11, n. 1, p. 1, doi. 10.1038/s41420-025-02385-0
- By:
- Publication type:
- Article
Prognostic Significance of the Combined Albumin-To-Alkaline Phosphatase Ratio (AAPR) and Haemoglobin–Albumin–Lymphocyte–Platelet (HALP) Score in Patients with Metastatic Renal Cell Carcinoma Treated by Targeted Therapy: A New Prognostic Combined Risk Scoring
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 5, p. 1742, doi. 10.3390/jcm14051742
- By:
- Publication type:
- Article
Comparing oncologic outcomes of partial and radical nephrectomy for T2 renal cell carcinoma: a propensity score matching cohort study and an external multicenter validation.
- Published in:
- World Journal of Urology, 2025, v. 43, n. 1, p. 1, doi. 10.1007/s00345-025-05561-0
- By:
- Publication type:
- Article
Construction of a prognostic risk model for clear cell renal cell carcinomas based on centrosome amplification-related genes.
- Published in:
- Molecular Genetics & Genomics, 2025, v. 300, n. 1, p. 1, doi. 10.1007/s00438-025-02237-7
- By:
- Publication type:
- Article
RELATO DE CASO: CANCER RENAL AVANÇADO COM TROMBOSE VENOSA ACOMETENDO VEIA CAVA INFERIOR E ATRIO DIREITO.
- Published in:
- Revista Foco (Interdisciplinary Studies Journal), 2025, v. 18, n. 1, p. 1, doi. 10.54751/revistafoco.v18n1-103
- By:
- Publication type:
- Article
Efficacy and safety of PD-1/PD-L1 inhibitors alone or in combination in the treatment of metastatic or advanced renal cell carcinoma: a network meta-analysis.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1524497
- By:
- Publication type:
- Article
Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFB.
- Published in:
- ImmunoTargets & Therapy, 2025, v. 14, p. 35, doi. 10.2147/ITT.S486609
- By:
- Publication type:
- Article
Sodium-Glucose Cotransporter 2 (SGLT2) as a Potential Biomarker and Target in Papillary Renal Cell Carcinoma.
- Published in:
- Clinical Genitourinary Cancer, 2025, v. 23, n. 2, p. N.PAG, doi. 10.1016/j.clgc.2025.102314
- By:
- Publication type:
- Article
Surgical Outcomes of Radical Nephrectomy and Inferior Vena Cava Thrombectomy Following Preoperative Systemic Immunotherapy: A Propensity Score Analysis.
- Published in:
- Clinical Genitourinary Cancer, 2025, v. 23, n. 2, p. N.PAG, doi. 10.1016/j.clgc.2025.102307
- By:
- Publication type:
- Article
Collecting Duct Carcinoma: Characteristics and Survival Outcomes From UroCCR Database (CDCSurv UroCCR n°141).
- Published in:
- Clinical Genitourinary Cancer, 2025, v. 23, n. 2, p. N.PAG, doi. 10.1016/j.clgc.2025.102305
- By:
- Publication type:
- Article
Comparison of Outcomes Between African American and European American Patients With Metastatic Clear Cell Renal Cell Carcinoma Receiving Immune Checkpoint Inhibitors.
- Published in:
- Clinical Genitourinary Cancer, 2025, v. 23, n. 2, p. N.PAG, doi. 10.1016/j.clgc.2025.102304
- By:
- Publication type:
- Article
Editorial for "Clear Cell Renal Cell Carcinoma: Characterizing the Phenotype of Von Hippel–Lindau Mutation Using MRI".
- Published in:
- 2025
- By:
- Publication type:
- Editorial